BR9913955A - Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular - Google Patents

Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular

Info

Publication number
BR9913955A
BR9913955A BR9913955-3A BR9913955A BR9913955A BR 9913955 A BR9913955 A BR 9913955A BR 9913955 A BR9913955 A BR 9913955A BR 9913955 A BR9913955 A BR 9913955A
Authority
BR
Brazil
Prior art keywords
comfortable
sustained
ophthalmic composition
eye therapy
release ophthalmic
Prior art date
Application number
BR9913955-3A
Other languages
English (en)
Inventor
Ernesto J Castillo
Ruma Sarkar
Onkar N Singh
Alan L Weiner
Cody Yarborough
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR9913955A publication Critical patent/BR9913955A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>''COMPOSIçãO OFTALMOLóGICA CONFORTáVEL E DE LIBERAçãO SUSTENTADA E MéTODO PARA TERAPIA OCULAR''<D>. Descrevem-se formulações oftalmológicas de liberação sustentada e desconforto reduzido. Também se descrevem métodos de tratamento que compreendem a administração dessas formulações topicamente ao olho quando em necessidade das mesmas.
BR9913955-3A 1998-09-25 1999-09-22 Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular BR9913955A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10195998P 1998-09-25 1998-09-25
PCT/US1999/021957 WO2000018316A2 (en) 1998-09-25 1999-09-22 Sustained release, and comfortable ophthalmic composition and method for ocular therapy

Publications (1)

Publication Number Publication Date
BR9913955A true BR9913955A (pt) 2001-06-12

Family

ID=22287389

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913955-3A BR9913955A (pt) 1998-09-25 1999-09-22 Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular

Country Status (8)

Country Link
US (1) US6486208B1 (pt)
EP (1) EP1115406A4 (pt)
JP (1) JP2003517441A (pt)
AR (1) AR022099A1 (pt)
AU (1) AU761785B2 (pt)
BR (1) BR9913955A (pt)
CA (1) CA2345466C (pt)
WO (1) WO2000018316A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020198174A1 (en) * 2001-05-07 2002-12-26 Allergan Sales, Inc. Disinfecting and solubilizing steroid compositions
ATE253905T1 (de) * 1999-11-30 2003-11-15 Alcon Inc Verwendung von beta-rezeptorenblocker zur herstellung eines medikaments zur behandlung von krankheiten der äusseren retina
AU1770901A (en) * 2000-11-16 2002-05-27 Alcon Lab Inc Combination therapy for lowering and controlling intraocular pressure
US6752786B2 (en) * 2001-05-31 2004-06-22 Radiant Medical, Inc. Moving heat exchange catheter system
FR2837710B1 (fr) * 2002-03-26 2005-07-08 Innovations Pharma Ag Composition topique a base de resines echangeuses d'ions, notamment pour le traitement des erythemes
WO2005018646A1 (ja) * 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
WO2007015510A1 (ja) 2005-08-02 2007-02-08 Santen Pharmaceutical Co., Ltd. 熱的に不安定な薬物の分解抑制方法
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
ES2428868T3 (es) * 2006-07-28 2013-11-12 Novagali Pharma S.A. Composiciones que contienen compuestos de amonio cuaternario
SG176525A1 (en) * 2006-12-22 2011-12-29 Sigma Tau Ind Farmaceuti Gel useful for the delivery of ophthalmic drugs
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
SG187770A1 (en) 2010-08-12 2013-03-28 Univ Nanyang Tech A liposomal formulation for ocular drug delivery
EP2452669A1 (en) * 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmic composition
CN104208016A (zh) * 2013-05-29 2014-12-17 天津金耀集团有限公司 含有曲伏***素的眼部制剂
US9115109B2 (en) 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
WO2016016908A1 (en) 2014-07-28 2016-02-04 Sun Pharma Advanced Research Company Limited Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
CN108066283B (zh) * 2017-12-28 2020-03-24 兆科（广州）眼科药物有限公司 一种盐酸左倍他洛尔滴眼液的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US5093126A (en) * 1987-09-26 1992-03-03 Alcon Laboratories, Inc. Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer
US5182102A (en) * 1991-07-12 1993-01-26 Alcon Laboratories, Inc. Anti-glaucoma compositions
US5662919A (en) * 1994-11-21 1997-09-02 Alcon Laboratories, Inc. Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds

Also Published As

Publication number Publication date
WO2000018316A3 (en) 2000-11-16
CA2345466A1 (en) 2000-04-06
JP2003517441A (ja) 2003-05-27
US6486208B1 (en) 2002-11-26
AR022099A1 (es) 2002-09-04
AU6057199A (en) 2000-04-17
EP1115406A4 (en) 2003-03-05
AU761785B2 (en) 2003-06-12
WO2000018316A2 (en) 2000-04-06
EP1115406A2 (en) 2001-07-18
CA2345466C (en) 2007-01-23

Similar Documents

Publication Publication Date Title
BR9913955A (pt) Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
WO2002085248A3 (en) Prostanoids augment ocular drug penetration
AR041725A1 (es) Prevencion, tratamiento de la enfermedad sinucleinopatica y composicion farmacologica
SE9702860D0 (sv) New use
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
AU4438601A (en) Therapeutic combinations of antihypertensive and antiangiogenic agents
BR9814923A (pt) Método para tratamento de doença de alzheimer
HUP0400548A2 (hu) Belső szemnyomást csökkentő hatóanyag-kombinációk alkalmazása glaukoma kezelésére szolgáló gyógyszerkészítmények előállítására
BR9914631A (pt) Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades
DK0998287T3 (da) Anvendelse af levobupivacain
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
DE69429576D1 (de) Dermatansulfatezusammensetzung als antithromotisches mittel
AP1896A (en) The method of treating cancer
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
AU3401093A (en) Therapeutic agent for threatened abortion
EP1037622A4 (en) TAURIN DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISORDERS
WO1998024898A3 (en) Therapeutic composition comprising the kal protein and use of the kal protein
HUP0300566A2 (hu) Galantamin alkalmazása az Alzheimer-kórral összefüggő neuropszichiátriai viselkedésformák terápiájában
BRPI0411427A (pt) formulações de agentes antiinflamatórios não-esteróides para o tratamento de angiogênese ocular patológica
HUP9701606A2 (hu) Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
AU1662300A (en) Agent for lowering endothelin levels
BR0212274A (pt) Uso de estrogênios não-feminilizantes como agentes retinoprotetores para o tratamento de glaucoma

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI